February 2019, Jeuveau (pronounced Jū-vō) got its FDA seal of approval, marking the FOURTH Botox-like product on the market. So what makes it unique? Our team traveled to Cancun, Mexico for an Expert Summit to learn more and share with you!

​

First the name -- where did that come from? Well,  Jeuveau is inspired and rhymes with “nouveau”, a French term for new. So as the newest entrant onto the Botox scene, it is aptly named. It is the brainchild of the company Evolus, and the first toxin that is designer made for purely aesthetic use… no medical conditions treatment for Jeuveau, it is 100% for cosmetic use.

​

So what is the deal with Jeuveau, and how does it intend to make a splash? Is it really going to rival Botox? Well, time will tell but it is positioned as a designer or premium Botox. It was specifically designed and will be marketed to be just like Botox, only a little better. The marketing for the product is slick, with appeal screaming to the millennial mindset and sensibilities. Dubbed the “happy toxin” by the beauty industry and business insiders, it is targeted to appeal to the softer side of aesthetics. The idea is to blur the line between the beauty industry and cosmetic procedures, making Jeuveau the stepping stone from department beauty counter to in-office procedures.

​

Jeuveau is a bit hard to pronounce, so the company’s marketing machine coined it the NewTox, a much more easy term for toxin patients to understand AND pronounce.

​

How does Jeuveau compare to Botox? Both of these products are great with consistent results. Our office uses Jeuveau in a similar fashion to Botox, unit for unit. Those involved with the Jeuveau clinical trials have favorable feedback on the product, and state patients liked treatment as well.